FutureChem Co., Ltd. Logo

FutureChem Co., Ltd.

Develops radiopharmaceuticals and synthesis equipment for diagnostics and therapy.

220100 | KO

Overview

Corporate Details

ISIN(s):
KR7220100002
LEI:
Country:
South Korea
Address:
서울특별시 성동구 성수일로8길 59 평화빌딩 B동 3층(성수동2가), 서울특별시

Description

FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-09-15 00:00
[기재정정]투자판단관련주요경영사항(임상시험결과) (전립선암 치료용 [Lu177]Ludotadipep 방사성의약품 FC7…
Korean 25.0 KB
2025-09-04 00:00
투자판단관련주요경영사항(임상시험계획승인신청등결정) (전이성 거세저항성 전립선암 환자에서 [177Lu]루도타다이 펩의 유…
Korean 12.4 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.7 MB
2025-07-14 00:00
기업설명회(IR)개최
Korean 6.7 KB
2025-07-10 00:00
투자판단관련주요경영사항 (프로스타뷰([F18]플로라스타민)주사액 식품의약품안전처 신약 허가)
Korean 13.7 KB
2025-07-09 00:00
투자판단관련주요경영사항(임상시험결과) ([F18]Florastamin 제3상 임상시험 결과보고서 수령)
Korean 12.1 KB
2025-07-09 00:00
투자판단관련주요경영사항(임상시험결과) ([F18]Florastamin 제3상 임상시험 결과보고서 수령)
Korean 12.7 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-08 00:00
투자판단관련주요경영사항(임상시험결과) (전립선암 치료용 [Lu177]Ludotadipep 방사성의약품 FC705 의 국…
Korean 16.2 KB
2025-03-25 00:00
정기주주총회결과
Korean 22.4 KB
2025-03-14 00:00
사업보고서 (2024.12)
Korean 523.9 KB
2025-03-10 00:00
주주총회소집공고
Korean 171.6 KB
2025-03-10 00:00
주주총회소집결의
Korean 11.3 KB
2025-03-10 00:00
의결권대리행사권유참고서류
Korean 153.4 KB

Automate Your Workflow. Get a real-time feed of all FutureChem Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FutureChem Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FutureChem Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.